Stevens Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,599
Closed -$551K 1036
2018
Q2
$551K Sell
5,599
-14,075
-72% -$1.57M 0.02% 529
2018
Q1
$2.19M Buy
19,674
+12,617
+179% +$1.41M 0.08% 271
2017
Q4
$726K Buy
7,057
+903
+15% +$90K 0.03% 490
2017
Q3
$580K Buy
+6,154
New +$486K 0.02% 528
2017
Q1
Sell
-6,682
Closed -$526K 1181
2016
Q4
$526K Buy
+6,682
New +$519K 0.02% 560
2016
Q3
Sell
-7,552
Closed -$519K 1223
2016
Q2
$519K Buy
+7,552
New +$521K 0.02% 565
2016
Q1
Sell
-4,534
Closed -$282K 1186
2015
Q4
$282K Buy
+4,534
New +$277K 0.01% 715
2014
Q1
Sell
-9,626
Closed -$326K 1397
2013
Q4
$326K Buy
+9,626
New +$333K 0.01% 765

Other funds holding CMD

Stevens Capital Management's CMD Position: Q3 2018 in Review

Stevens Capital Management sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 5,599 shares — an estimated $551K sold.

Stevens Capital Management first reported a position in CMD in Q4 2013 and held it in 8 quarters. The position peaked at $2.19M in Q1 2018. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • Stevens Capital Management reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • Stevens Capital Management sold 5,599 Cantel Medical Corporation shares in Q3 2018, an estimated $551K.
  • Stevens Capital Management first reported a position in Cantel Medical Corporation in Q4 2013 and held it in 8 quarters.
  • Stevens Capital Management's Cantel Medical Corporation position peaked at $2.19M in Q1 2018.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Stevens Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.